Parkinson's disease is a chronic neurodegenerative pathology characterized by the progressive loss of dopaminergic neurons in the substantia nigra of the brain, with classic motor manifestations (resting tremor, rigidity, bradykinesia, alteratio… Read more.
9 factors with evidence, ordered from highest to lowest effectiveness. Information, not medical advice.
⏱ 3 min read
Parkinson's disease is a chronic neurodegenerative condition characterized by the progressive loss of dopaminergic neurons in the substantia nigra of the brain, with classic motor manifestations (resting tremor, rigidity, bradykinesia, postural disturbances) and non-motor manifestations that are often more disabling in the long term (sleep disturbances, constipation, hyposmia, depression, anxiety, cognitive decline, dysautonomia); it affects approximately 1-2% of people over 65 and its prevalence increases with population aging. Although there is no cure, there are effective treatments for symptoms and active lines of research on disease modification.
Levodopa: the most effective drug for motor symptoms; a dopamine precursor given in combination with carbidopa or benserazide (peripheral decarboxylase inhibitors). Although it revolutionized treatment, its long-term use is associated with motor fluctuations and dyskinesias.
Dopamine agonists (pramipexole, ropinirole, rotigotine): an alternative or add-on, especially in younger patients.
MAO-B inhibitors (selegiline, rasagiline, safinamide): modest symptomatic effect and possible neuroprotective benefit.
COMT inhibitors (entacapone, opicapone): enhance the effect of levodopa.
Anticholinergics (trihexyphenidyl): especially for tremor; limited by adverse effects in older adults.
Amantadine: tremor and dyskinesias.
Apomorphine, continuous infusion: for advanced fluctuations.
Deep brain stimulation (DBS): in selected cases with advanced fluctuations.
Regular exercise: as important as drugs. Improves motor function, balance, mood, sleep, and possibly progression. Specific exercises: tai chi, dance, Nordic walking, non-contact boxing (Rock Steady Boxing), mobility and balance exercises.
Specialized physical therapy and occupational therapy.
Speech therapy: for speech and swallowing disorders.
Sufficient, good-quality sleep.
Mucuna pruriens: a natural source of L-DOPA. In patients with limited access to pharmaceutical levodopa or who prefer alternatives, it may be useful. Clinical data comparable to pharmaceutical levodopa in some studies. Important: dosing, adverse effects, and pharmacological considerations similar to levodopa; requires specialized medical supervision. Do not combine with levodopa without supervision because of the risk of additive toxicity.
Coenzyme Q10: modest support in early Parkinson's.
Creatine: modest support in some studies.
Vitamin D: deficiencies are very common in Parkinson's; correction is reasonable.
Omega-3 EPA/DHA: modest support for cognitive function and mood.
Vitamin B12, folate: correct deficiencies (common with prolonged levodopa use).
Specific probiotics: growing support for constipation (universal in Parkinson's) and possibly disease progression (microbiota-brain axis).
Green tea EGCG, curcumin, resveratrol, citicoline: preclinical support, modest clinical data.
Some drugs can worsen Parkinson's and should be avoided or used with extreme caution: - Classic antipsychotics (haloperidol, risperidone): worsen motor symptoms. - Metoclopramide, sulpiride: dopamine antagonists. - Some sedating antihistamines.
Resting tremor, slowness of movement, rigidity, gait disturbances, micrographia (small handwriting), significant hyposmia, REM behavior disorder, and late-onset depression without a clear cause require neurological evaluation. Early diagnosis allows appropriate treatment to be started and entry into clinical studies when that is an option.
Parkinson's is best managed with a multidisciplinary approach: drug treatment optimized by a neurologist, regular exercise as a therapeutic component as important as drugs, specialized physical and occupational therapy, attention to non-motor symptoms (constipation, sleep, mood, cognition, dysautonomia), and appropriate nutritional and supplement management. Mucuna pruriens is a natural alternative to levodopa with a real pharmacological profile that requires medical supervision. Active lines of research (disease-modifying therapies, anti-synuclein antibodies, gene therapy, stem cells) promise changes in the landscape in the coming decades.
⏱ 3 min read
Parkinson's disease is a chronic neurodegenerative condition characterized by the progressive loss of dopaminergic neurons in the substantia nigra of the brain, with classic motor manifestations (resting tremor, rigidity, bradykinesia, postural disturbances) and non-motor manifestations that are often more disabling in the long term (sleep disturbances, constipation, hyposmia, depression, anxiety, cognitive decline, dysautonomia); it affects approximately 1-2% of people over 65 and its prevalence increases with population aging. Although there is no cure, there are effective treatments for symptoms and active lines of research on disease modification.
Levodopa: the most effective drug for motor symptoms; a dopamine precursor given in combination with carbidopa or benserazide (peripheral decarboxylase inhibitors). Although it revolutionized treatment, its long-term use is associated with motor fluctuations and dyskinesias.
Dopamine agonists (pramipexole, ropinirole, rotigotine): an alternative or add-on, especially in younger patients.
MAO-B inhibitors (selegiline, rasagiline, safinamide): modest symptomatic effect and possible neuroprotective benefit.
COMT inhibitors (entacapone, opicapone): enhance the effect of levodopa.
Anticholinergics (trihexyphenidyl): especially for tremor; limited by adverse effects in older adults.
Amantadine: tremor and dyskinesias.
Apomorphine, continuous infusion: for advanced fluctuations.
Deep brain stimulation (DBS): in selected cases with advanced fluctuations.
Regular exercise: as important as drugs. Improves motor function, balance, mood, sleep, and possibly progression. Specific exercises: tai chi, dance, Nordic walking, non-contact boxing (Rock Steady Boxing), mobility and balance exercises.
Specialized physical therapy and occupational therapy.
Speech therapy: for speech and swallowing disorders.
Sufficient, good-quality sleep.
Mucuna pruriens: a natural source of L-DOPA. In patients with limited access to pharmaceutical levodopa or who prefer alternatives, it may be useful. Clinical data comparable to pharmaceutical levodopa in some studies. Important: dosing, adverse effects, and pharmacological considerations similar to levodopa; requires specialized medical supervision. Do not combine with levodopa without supervision because of the risk of additive toxicity.
Coenzyme Q10: modest support in early Parkinson's.
Creatine: modest support in some studies.
Vitamin D: deficiencies are very common in Parkinson's; correction is reasonable.
Omega-3 EPA/DHA: modest support for cognitive function and mood.
Vitamin B12, folate: correct deficiencies (common with prolonged levodopa use).
Specific probiotics: growing support for constipation (universal in Parkinson's) and possibly disease progression (microbiota-brain axis).
Green tea EGCG, curcumin, resveratrol, citicoline: preclinical support, modest clinical data.
Some drugs can worsen Parkinson's and should be avoided or used with extreme caution: - Classic antipsychotics (haloperidol, risperidone): worsen motor symptoms. - Metoclopramide, sulpiride: dopamine antagonists. - Some sedating antihistamines.
Resting tremor, slowness of movement, rigidity, gait disturbances, micrographia (small handwriting), significant hyposmia, REM behavior disorder, and late-onset depression without a clear cause require neurological evaluation. Early diagnosis allows appropriate treatment to be started and entry into clinical studies when that is an option.
Parkinson's is best managed with a multidisciplinary approach: drug treatment optimized by a neurologist, regular exercise as a therapeutic component as important as drugs, specialized physical and occupational therapy, attention to non-motor symptoms (constipation, sleep, mood, cognition, dysautonomia), and appropriate nutritional and supplement management. Mucuna pruriens is a natural alternative to levodopa with a real pharmacological profile that requires medical supervision. Active lines of research (disease-modifying therapies, anti-synuclein antibodies, gene therapy, stem cells) promise changes in the landscape in the coming decades.